#USA #Houston #TR-FRET #Sino Biological #SwiftFluo®

SwiftFluo® TR-FRET Kits by Sino Biological: A Game Changer in Kinase Research

Sino Biological, Inc. has officially announced the launch of its SwiftFluo® TR-FRET Kinase Assay Kits, a groundbreaking solution aimed at expediting the detection of kinase activity and screening for kinase inhibitors. This innovative product is designed to meet the high-performance requirements of today's fast-paced research environment.

What Makes SwiftFluo® TR-FRET Kits Stand Out?

These new kits utilize Time-Resolved Förster Resonance Energy Transfer (TR-FRET) technology, known for its exceptional sensitivity and superior signal-to-noise ratio, which allows researchers to achieve robust and reproducible results. Unlike traditional methods such as radioisotopic assays, ELISA, or intensity-based fluorescence techniques, the SwiftFluo® TR-FRET kits promise rapid, reliable, and scalable screening capabilities.

With optimization for profiling over 60 Tyrosine Kinases (TKs), 150 Serine/Threonine Kinases (STKs), and 15 Cyclin-Dependent Kinases (CDKs), the kits offer extensive coverage of key signaling pathways in biological research. This breadth of coverage is vital for researchers working to understand complex cellular mechanisms and develop effective therapeutic strategies.

Flexible Solutions for Personalized Research Needs

In addition to the kits, Sino Biological provides a range of related substrates and corresponding biologically active kinases as standalone products. This strategy enhances the flexibility for researchers, allowing them to customize their assays according to specific project requirements. The ability to conduct homogenous assays without the need for washing enhances the workflow, making it easier for researchers to adopt these kits in their labs.

User-Friendly Design Enhances Research Efficiency

The easy-to-use format of the SwiftFluo® TR-FRET kits aligns with standard high-throughput screening (HTS) platforms. Dr. Rob Burgess, the Commercial Director of Sino Biological US, emphasizes that this capability reduces assay development time significantly and streamlines various workflow processes.

"Our aim is to eliminate the complexity in kinase assays, allowing researchers to easily add reagents and read results, ultimately driving scientific progress," Dr. Burgess stated.

Vision for Global Research Community

Dr. Jie Zhang, CEO of Sino Biological, expressed enthusiasm about presenting the SwiftFluo® TR-FRET kits to the global research community. He remarked that the design of these kits reflects a careful balance of user-friendliness, cost-effectiveness, and reproducibility—factors that are essential for the success of high-throughput screening campaigns.

```markdown

Explore the New Era in Drug Discovery

Researchers interested in exploring how the SwiftFluo® TR-FRET kits can be integrated into their drug discovery platforms are encouraged to visit www.sinobiological.com where they can also download the technical Q&A manual for further insights.
```

About Sino Biological

Founded in 2007, Sino Biological is a leading global biotechnology company specializing in high-quality recombinant proteins, antibodies, and CRO services. With a presence in over 90 countries, the company supports basic research, drug discovery, vaccine development, and diagnostics through its comprehensive product portfolio and innovative research platforms.

Looking Ahead

Sino Biological remains committed to innovation, continually enhancing its offerings to enable breakthroughs in the life sciences sector. Through the SwiftFluo® TR-FRET kits, the company contributes to advancing our understanding of kinase biology and facilitating the discovery of new therapeutic agents, propelling the biotechnology field forward.

For media inquiries or collaboration opportunities, please contact Sino Biological, Inc. at email protected] or visit [www.sinobiological.com.